Medici: On March 10th, sold 300 shares via margin short selling, with a margin financing and securities lending balance of 317 million yuan.

NightAirdropper · 2026-03-11T14:28:16+00:00

On March 10th, Medici received financing of 24.0943 million yuan, with a net sell of 621,900 yuan, and a financing balance of 316 million yuan. In terms of securities lending, 300 shares were sold, with a securities lending balance of 10,400 shares, and the total margin financing and securities lending balance was 317 million yuan. This data is compiled from publicly available information and does not constitute investment advice.

NightAirdropper

2026-03-11 14:28:16

Abstract generation in progress

Securities Star News: On March 10th, Medici (688202) had a margin buy-in of 24.0943 million yuan, a margin repayment of 24.7162 million yuan, a net margin sell of 621,900 yuan, and a margin balance of 316 million yuan.

Regarding securities lending, on that day, 300 shares were sold short, 0 shares were repaid, resulting in a net short sale of 300 shares. The remaining short position was 10,400 shares. Over the past 20 trading days, there have been 11 days with net short sales.

The total margin and securities lending balance was 317 million yuan, down 0.19% from yesterday.

Quick Facts

Margin Trading and Securities Lending: Margin trading means the securities company borrows money to investors to buy stocks. When due, the principal and interest are repaid together. Securities lending can be understood as investors borrowing stocks to sell; they return the stocks and pay interest when due. Generally, investors buy stocks on margin if they are optimistic about the stock price, and sell short if they are bearish.

The above content is compiled from publicly available information by Securities Star, generated by AI algorithm (Wang Xin Suan Bei 310104345710301240019), and does not constitute investment advice.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes